63. Idiopathic thrombocytopenic purpura Clinical trials / Disease details
Clinical trials : 391 / Drugs : 235 - (DrugBank : 50) / Drug target genes : 49 - Drug target pathways : 139
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2200060164 | 2022-06-01 | 2022-05-21 | Application of immune cell detection in disease prediction and therapeutic drug selection in patients with primary immune thrombocytopenia | Application of immune cell detection in disease prediction and therapeutic drug selection in patients with primary immune thrombocytopenia | primary immune thrombocytopenia (ITP) | Gold Standard:Clinical outcome;Index test:Immunocell detection; | Anhui Provincial Hospital | NULL | Pending | Both | Target condition:20;Difficult condition:0 | N/A | China |